Ultrasound-Responsive Biomimetic Superhydrophobic Drug-Loaded Mesoporous Silica Nanoparticles for Treating Prostate Tumor
Open Access
- 5 April 2023
- journal article
- research article
- Published by MDPI AG in Pharmaceutics
- Vol. 15 (4) , 1155
Abstract
Interfacial nanobubbles on a superhydrophobic surface can serve as ultrasound cavitation nuclei for continuously promoting sonodynamic therapy, but their poor dispersibility in blood has limited their biomedical application. In this study, we proposed ultrasound-responsive biomimetic superhydrophobic mesoporous silica nanoparticles, modified with red blood cell membrane and loaded with doxorubicin (DOX) (F-MSN-DOX@RBC), for RM-1 tumor sonodynamic therapy. Their mean size and zeta potentials were 232 ± 78.8 nm and −35.57 ± 0.74 mV, respectively. The F-MSN-DOX@RBC accumulation in a tumor was significantly higher than in the control group, and the spleen uptake of F-MSN-DOX@RBC was significantly reduced in comparison to that of the F-MSN-DOX group. Moreover, the cavitation caused by a single dose of F-MSN-DOX@RBC combined with multiple ultrasounds provided continuous sonodynamic therapy. The tumor inhibition rates in the experimental group were 71.5 8 ± 9.54%, which is significantly better than the control group. DHE and CD31 fluorescence staining was used to assess the reactive oxygen species (ROS) generated and the broken tumor vascular system induced by ultrasound. Finally, we can conclude that the combination of anti-vascular therapy, sonodynamic therapy by ROS, and chemotherapy promoted tumor treatment efficacy. The use of red blood cell membrane-modified superhydrophobic silica nanoparticles is a promising strategy in designing ultrasound-responsive nanoparticles to promote drug-release.Keywords
Funding Information
- Natural Science Foundation of China (81801716, 82171961, 81922033, 82151316, 81901769, 82001852, SGDX20190917094601717, JCYJ20210324141216040, 2022YFF0706504)
- Shenzhen Science and Technology (81801716, 82171961, 81922033, 82151316, 81901769, 82001852, SGDX20190917094601717, JCYJ20210324141216040, 2022YFF0706504)
- National Key Research and Development Program of China (81801716, 82171961, 81922033, 82151316, 81901769, 82001852, SGDX20190917094601717, JCYJ20210324141216040, 2022YFF0706504)
This publication has 67 references indexed in Scilit:
- Hyperthermia-triggered drug delivery from temperature-sensitive liposomes using MRI-guided high intensity focused ultrasoundJournal of Controlled Release, 2012
- PEG-Functionalized Magnetic Nanoparticles for Drug Delivery and Magnetic Resonance Imaging ApplicationsPharmaceutical Research, 2010
- Light-responsive nanogated ensemble based on polymer grafted mesoporous silica hybrid nanoparticlesChemical Communications, 2010
- Contrast Agent Kinetics in the Rabbit Brain During Exposure to Therapeutic UltrasoundUltrasound in Medicine & Biology, 2010
- HPMA copolymers: Origins, early developments, present, and future☆Advanced Drug Delivery Reviews, 2010
- Ultrasound Microbubble Contrast Agents: Fundamentals and Application to Gene and Drug DeliveryAnnual Review of Biomedical Engineering, 2007
- Superstability of Surface NanobubblesPhysical Review Letters, 2007
- Injection of PEGylated liposomes in rats elicits PEG-specific IgM, which is responsible for rapid elimination of a second dose of PEGylated liposomesJournal of Controlled Release, 2006
- Stimuli‐Responsive Controlled Drug Release from a Hollow Mesoporous Silica Sphere/Polyelectrolyte Multilayer Core–Shell StructureAngewandte Chemie International Edition, 2005
- Cancer cells compress intratumour vesselsNature, 2004